KOLČAVA, Jan, Monika HULOVÁ,
Yvonne BENEŠOVÁ,
Josef BEDNAŘÍK a
Pavel ŠTOURAČ. The value of anti-JCV antibody index assessment in multiple sclerosis patients treated with natalizumab with respect to demographic, clinical and radiological findings.
MULTIPLE SCLEROSIS AND RELATED DISORDERS. OXFORD: ELSEVIER SCI LTD, 2019, roč. 30, MAY 2019, s. 187-191. ISSN 2211-0348. Dostupné z: https://dx.doi.org/10.1016/j.msard.2019.02.019.